Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less (Q81097337)
Jump to navigation
Jump to search
scientific article published on 05 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less |
scientific article published on 05 September 2007 |
Statements
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial (English)
Bernard J Gersh
Benjamin M Scirica
David A Morrow
Hanoch Hod
Luiz Belardinelli
Chester M Hedgepeth
Peter Molhoek
Freek W A Verheugt
Carolyn H McCabe
Eugene Braunwald
5 September 2007